Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 46INDUSTRY 10UNKNOWN 6OTHER_GOV 3NETWORK 2

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1

Conditions

Stomach Neoplasms 1Neoplasm Metastasis 1Carcinoma, Non-Small-Cell Lung 1Advanced Gastric Cancer 1

Interventions

Cisplatin 49Capecitabine 42Radiotherapy 33Oxaliplatin 33Gemcitabine 33apatinib 32Cyclophosphamide 32Drug Therapy 31Paclitaxel 30Carboplatin 29tislelizumab 27Irinotecan 27Fluorouracil 26Docetaxel 26Bevacizumab 23Surgical Procedures, Operative 20Nivolumab 19pembrolizumab 18fludarabine 18Metformin 16Exercise 16Radiation 15camrelizumab 14S 1 (combination) 14Control Groups 14Blood Specimen Collection 14Pemetrexed 13Standard of Care 12anlotinib 11Neoadjuvant Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × titanium silicide × Clear all
NCT03137004 2017-05-08

Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer

Fujian Cancer Hospital

Phase 2 Unknown
47 enrolled
Gastrointestinal

Advanced Gastric Cancer

NCT00874328 2010-10-25

A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

National Cancer Center, Korea

Phase 1/2 Unknown
74 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00512681 2009-09-18

TIROX2

National Cancer Center, Korea

Phase 2 Completed
44 enrolled
Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡